ArTS Archivio della ricerca di Trieste

MAGLI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.785
AS - Asia 902
EU - Europa 456
Continente sconosciuto - Info sul continente non disponibili 206
SA - Sud America 92
AF - Africa 15
OC - Oceania 4
Totale 3.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.711
SG - Singapore 346
IT - Italia 302
BD - Bangladesh 128
KR - Corea 126
VN - Vietnam 126
CN - Cina 65
BR - Brasile 61
CA - Canada 40
FR - Francia 28
HK - Hong Kong 27
IN - India 26
PL - Polonia 24
GB - Regno Unito 22
AR - Argentina 18
MX - Messico 14
SE - Svezia 14
ES - Italia 8
FI - Finlandia 8
JM - Giamaica 8
TR - Turchia 8
UA - Ucraina 8
DE - Germania 7
AT - Austria 6
NL - Olanda 6
IQ - Iraq 5
PH - Filippine 5
RU - Federazione Russa 5
AU - Australia 4
CO - Colombia 4
DK - Danimarca 4
ID - Indonesia 4
JP - Giappone 4
PK - Pakistan 4
SA - Arabia Saudita 4
ZA - Sudafrica 4
AZ - Azerbaigian 3
BG - Bulgaria 3
EC - Ecuador 3
IE - Irlanda 3
IL - Israele 3
JO - Giordania 3
MA - Marocco 3
PY - Paraguay 3
UZ - Uzbekistan 3
AL - Albania 2
CR - Costa Rica 2
DZ - Algeria 2
KE - Kenya 2
MY - Malesia 2
NI - Nicaragua 2
PR - Porto Rico 2
SV - El Salvador 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
SI - Slovenia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.256
Salva come PNG Salva come JPEG
Città #
Ashburn 280
San Jose 256
Council Bluffs 249
Singapore 249
Seoul 126
Milan 58
New York 49
Ho Chi Minh City 39
Trieste 38
Columbus 34
Santa Clara 33
Beijing 32
Houston 30
Los Angeles 30
Phoenix 29
Chicago 28
Hong Kong 26
Hanoi 24
Fairfield 21
Rome 20
Miano 19
Seattle 19
Buffalo 16
Dallas 16
Ann Arbor 14
Da Nang 14
Haiphong 12
Zgierz 12
Montreal 11
Wilmington 11
Atlanta 10
Lauterbourg 10
Orem 10
Alessandria 9
Denver 9
Jacksonville 9
Palermo 9
Warsaw 9
Cambridge 8
Charlotte 8
Olive Branch 8
Princeton 8
Salt Lake City 8
Brooklyn 7
Philadelphia 7
São Paulo 7
Florence 6
London 6
Mexico City 6
Mumbai 6
Naples 6
Toronto 6
Turin 6
Woodbridge 6
Chandler 5
Chennai 5
Kingston 5
Lappeenranta 5
Poplar 5
Washington 5
Augusta 4
Boardman 4
Cary 4
Clayton 4
Elk Grove Village 4
New Delhi 4
Palm Bay 4
Stockholm 4
Tokyo 4
Amman 3
Biên Hòa 3
Boydton 3
Brisbane 3
Brønshøj 3
Cincinnati 3
Colorado Springs 3
Dayton 3
Detroit 3
Dublin 3
Frankfurt am Main 3
Greenville 3
Istanbul 3
Izmir 3
Johannesburg 3
Louisville 3
Manchester 3
Moscow 3
North Kansas City 3
Querétaro 3
San Francisco 3
San Juan 3
Shanghai 3
Tampa 3
Tashkent 3
Vienna 3
Abbeville 2
Afragola 2
Agawam 2
Albano Laziale 2
Annapolis 2
Totale 2.133
Salva come PNG Salva come JPEG
Nome #
Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells. 154
Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma 129
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 83
18F-Choline-PET-CT (PET) in N stage and radiation treatment planning (RTP) of prostate cancer patients (PCap) at High or unfavorable/intermediate risk (HUIR) 75
A multicenter study of the prognosis and treatment of adult brain ependymonal tumors. 69
Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: bowel dose-volume effect quantification in a multicentric cohort study 65
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time? 62
The Prognostic Role of Preoperative PSMA PET/CT in cN0M0 pN+ Prostate Cancer: A Multicenter Study 61
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 58
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2 54
Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy 52
PREDICTORS FOR RECTAL AND INTESTINAL ACUTE TOXICITIES DURING PROSTATE CANCER HIGH-DOSE 3D-CRT: RESULTS OF A PROSPECTIVE MULTICENTER STUDY 51
A pilot study on the Vanderbilt head and neck symptom survey Italian version (VHNSS-IT) to test its feasibility and utility in routine clinical practice 49
Assessment of PTV margins accounting for prostate intrafraction motion in SBRT with online IGRT 45
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or Gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial 44
COVID-19 outbreak and cancer radiotherapy disruption in italy: Survey endorsed by the italian association of radiotherapy and clinical oncology (AIRO) 44
Prostate Cancer Treatment-Related Toxicity: Comparison between 3D-Conformal Radiation Therapy (3D-CRT) and Volumetric Modulated Arc Therapy (VMAT) Techniques 43
Comparison of self-reported acute urinary incontinence in pts treated with adjuvant or salvage IMRT 43
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 42
Adaptive radiotherapy nel trattamento radioterapico stereotassico ipofrazionato del tumore della prostata: Dose Tracking vs Re-Optimization 42
Assicurazione di qualità nella radioterapia ad intensità modulata 42
Comparison of self-reported acute urinary incontinence in patients treated with adjuvant or salvage post-prostatectomy intensity modulated-radiotherapy (IMRT) 41
Treatment of muscle-invasive bladder cancer in patients without comorbidities and fit for surgery: Trimodality therapy vs radical cystectomy. Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 40
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 39
An image-guided SBRT phase II study with a dose of 42 Gy in 7 fractions for the localized prostate cancer 38
Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions 38
3T-MRI in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for CT-registration 36
CONTROVERSY PERSISTS OVER THE ACTUAL DOSE–VOLUME RELATIONSHIP AND INDEED WHETHER THE PENILE BULB IS JUST A SURROGATE FOR OTHER NEARBY CRITICAL STRUCTURES, ESPECIALLY GIVEN ITS LIMITED ROLE IN DEVELOPMENT AND MAINTENANCE OF ERECTIONS 34
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer 33
Hyperfractionated radiotherapy for T2N0 glottic carcinoma: a retrospective analysis at 10 years follow-up in a series of 60 consecutive patients 32
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO). 32
Early results of PRO-EPI: PROspective multicenter observational study on elective pelvic nodes irradiation in patients with intermediate/high/very high-risk non-metastatic prostate cancer submitted to radical, adjuvant, or salvage radiotherapy with or without concomitant androgen deprivation therapy 32
Correlation Between Dose-Volume Constraints and Late Rectum Bleeding in Patients Treated for Prostate Cancer at Dose Between 70 and 76 Gy 31
Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects 31
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 30
Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation 30
Assessment of PTV Margins Accounting for Prostate Intrafraction Motion in SBRT with Online IGRT 29
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study 29
European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study 29
Safety and Efficacy of POstoPerative Ablative RadioTherapy (POPART) for Post-Prostatectomy Biochemical Recurrence 28
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial 28
Androgen Deprivation and Late Rectal Bleeding After Radiotherapy for Prostate Carcinoma 28
Daily Sodium Butyrate Enema for the Prevention of Radiation Proctitis in Prostate Cancer Patients Undergoing Radical Radiation Therapy: Results of a Multicenter Randomized Placebo-Controlled Dose-Finding Phase 2 Study 27
Breast leiomyosarcoma with myxoid aspects 26
Toxicity profile with hypofractionated RT for localized prostate cancer: compared 3D-CRT vs VMAT 26
Management of de Novo Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) and the Role of Radiation Therapy: A Consensus by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 25
Observation With or Without Subsequent Salvage Therapy for Pathologically Node-positive Prostate Cancer With Negative Conventional Imaging: Results From a Large Multicenter Cohort 25
Hypofractionated simultaneous integrated boost (IMRT-SIB) with pelvic nodal irradiation and concurrent androgen deprivation therapy for high-risk prostate cancer: results of a prospective phase II trial. 25
Dose-effect relationship for early late incontinence after IMRT in post-prostatectomy patients 25
Lymphopenia after whole-pelvis Radiotherapy in prostate Cancer patients is a major predictor of late patient-reported Intestinal Toxicity 24
Predictors of toxicities and oncological outcomes following postoperative ablative radiotherapy (POPART) for biochemical recurrence 23
IMRT with simultaneous integrated boost and concurrent chemiotherapy for locoregionally advanced oropharynx squamous cell carcinoma: preliminary results 23
PATIENT-SPECIFIC QA OF IMRT PLANS BY EMPLOYING AN EPID-BASED DOSE PREDICTION ALGORITHM 23
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT 23
Tecnologie integrate nel trattamento oncologico dei tumori Head & Neck Innovazioni della radioterapia di interesse ORL 23
Why we should take care of the competing risk bias in survival analysis: A phase II trial on the toxicity profile of radiotherapy for prostate cancer 23
Prospective longitudinal evaluation of quality of life after prostate cancer IMR 22
MRI-guided contouring in SBRT of the prostate for localized disease 22
QUALITY INDICATORS OF INTENSITY MODULATED-IMAGE GUIDED RADIOTHERAPY (IM-IGRT) CONCOMITANT TO CHEMOTHERAPY (CT): A BENCH-MARKING ANALYSIS FOR CLINICAL AND TECHNICAL GOVERNANCE 22
Toxicity at 1 Year After Stereotactic Body Radiation Therapy in 3 Fractions for Localized Prostate Cancer 22
Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: A multicenter study 22
Erectile dysfunction after prostate three-dimensional conformal radiation therapy: correlation with the dose to the bulb of the penis 22
Ruolo della TC/PET con 18F-colina nella stadiazione linfonodale e planning radioterapico nei pazienti con carcinoma della prostate a rischio alto ed intermedio sfavorevole 21
In prostate cancer patients (PC), PET-CT 18F-choline (FC) can incidentally discover un related diseases: our experience in 573 cases 21
Whole-pelvic nodal irradiation with hypofractionated simultaneous integrated boost for high-risk prostate cancer: outcome and late toxicity. 21
Quality of life after whole pelvis RT for prostate cancer: results from a prospective study 21
Pelvic IMRT with hypofractionated SIB to prostate for high-risk prostate cancer: a phase II study 21
Penalized-Survival Nomogram Predicts 5-Year Metastasis-Free Survival After Salvage Radiotherapy for Postprostatectomy Patients: A Multicenter Study 21
Phase II trial of pelvic nodal irradiation with hypofractionated IMRTSIB for high-risk prostate cancer 20
Laryngeal long-term morbility after supreglottic laryngectomy and postoperative radiation therapy 20
SBRT for Prostate Cancer in 3 fractions: Acute Toxicity Rates from a Prospective Multicenter Study 20
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors 20
Longitudinal assessment of the impact of pelvic nodal radiotherapy on lymphopenia in PCa treatment 19
DEVELOPMENT OF A SET OF NOMOGRAMS TO PREDICT ACUTE LOWER GASTROINTESTINAL TOXICITY FOR PROSTATE CANCER 3D-CRT 19
Unscheduled presentations of urological cancer outpatients in an oncology clinic: a single institution retrospective study 19
Image-guided hypofractionated radiotherapy for localized prostate cancer with 42Gy in 7 fractions: radiobiogy and preliminary clinical results of a phase II study 19
The influence of calculation parameters on the patient-QA of p-SBRT plans with VMAT 19
Radioterapia Oncologica 18
Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana Linfomi 18
Retrospective assessment of treatment planning quality in prostate SBRT 18
Linee guida carcinoma della prostata. AIOM edizione 2019 18
Predictors of Rectal Acute Toxicity in High-Dose 3D-CRT for Prostate Cancer. Results From a Prospective Multi-Centric Study Performed by the AIRO National Working Group on Prostate Irradiation 18
Stereotactic body radiation therapy for liver metastases: local control and radiological response as a prognostic factor 18
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I 18
RT for the management of locally advanced rectal cancer: Don't throw the baby with the bath water! 17
SALVAGE ELECTIVE PELVIC NODAL IRRADIATION (ENRT) COMBINED WITH FOCAL NODAL STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN THE NODAL METACHRONOUS OLIGOMETASTATIC CASTRATION-NAIVE PROSTATE CANCER: A TWOINSTITUTION EXPERIENCE 17
Dose-effect relationship for 1-year incontinence after post-prostatectomy intensitymodulated radiotherapy (MRT) 17
Radioterapia stereotassica body (42Gy in 7 frazioni settimanali) nei tumori localizzati della prostata: valutazioni radiobiologiche e primi risultati 17
La radioterapia nel trattamento degli adenomi ipofisari: risultati e prospettive 17
Il ruolo della radioterapia nel linfoma di Hodgkin: luci e ombre agli arbori del XXI secolo 17
Stereotactic Radiotherapy for Localised Prostate Cancer: Time to Clarify the Possible Impact of Concurrent Androgen Deprivation Therapy 17
IG-SBRT for localized prostate cancer: clinical results and late toxicity of a phase-II study 17
The role of SBRT in oligorecurrent and oligoprogressive prostate cancer: a multi-institutional study 17
IGRT con 3D-CRT ipofrazionata nel carcinoma prostatico a rischio intermedio mediante marcatori fiduciali intraprostatici: risultati di studio di fase II 16
Le metastasi cerebrali: aspetti diagnostici e terapeutici 16
Stereotactic Radiotherapy and Androgen Deprivation Therapy for Localized Prostate Cancer: A Retrospective Mono-institutional Experience 16
STEREOTACTIC BODY RADIOTHERAPY FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER. TOXICITY RESULTS OF PHASE II STUDY 16
PRACTICE PATTERNS FOR PROSTATE CANCER IN NINE CENTRAL AND NORTHERN ITALY RADIATION ONCOLOGY CENTERS: A SURVEY INCLUDING 1759 PATIENTS TREATED DURING TWO DECADES (1980–1998) 16
Il ruolo della radioterapia nel trattamento integrato del carcinoma del retto e giunzione retto-sigma 16
FDG-PET/CT for target volume delineation in the intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and concurrent chemotherapy (CHT) for locoregionally advanced oropharynx squamous cell carcinoma: preliminary resuls 15
Totale 3.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.441
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202217 0 0 0 2 0 0 2 0 3 3 2 5
2022/202321 2 2 3 0 3 4 0 1 3 0 3 0
2023/202410 0 1 1 0 1 1 2 2 0 0 0 2
2024/202527 1 0 0 3 3 3 3 4 3 2 2 3
2025/20262.294 6 0 2 267 174 230 95 75 379 549 336 181
2026/2027966 240 326 400 0 0 0 0 0 0 0 0 0
Totale 3.460